• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CFS Clinical selects C3i for global technology support

CFS Clinical selects C3i for global technology support

March 14, 2014
CenterWatch Staff

C3i, a provider of service desk support and business process outsourcing (BPO) services for the life sciences industry, has been selected by CFS Clinical to provide global 24x365 multilingual technology support services for their Site Activation and Investigator Payment Services.

CFS Clinical is a technology-enabled service provider focused on site startup and investigator payments for clinical trials. The company was recently acquired by DrugDev—an interactive network and data sharing platform for 80,000+ clinical trial doctors worldwide.

The partnership between C3i and CFS Clinical started in March 2013 with a training engagement. This included a 30-minute eLearning module developed in English and a translated Spanish version. CFS’ satisfaction with the delivered training services led to expanding the partnership between the two companies, and as of February 28, C3i began providing global 24x365 multilingual technology support services for CFS’ Site Startup and Global Payment Services systems. The service desk is supporting active clinical trial sites in nearly 50 countries and 12 languages, staffed out of C3i’s Sofia Operations Center. Later in 2014, additional languages will be added to manage CFS’ continued scaling, supported out of C3i’s Dalian Operations Center

“C3i’s industry and custom technology support expertise, reputation and global multilingual abilities were all factors that influenced our decision to select C3i in this endeavor. We already had a positive experience with C3i’s capabilities and professionalism, which they demonstrated by the earlier training development engagement,” said Greg Seminack, president of CFS Clinical. C3i’s ability to support proprietary applications also was a key factor in their selection of C3i as a partner.

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing